EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FUS is an N 1- and N 6-methyladenosine-binding protein

Xiaochen Liang, Ting Zhao, Xiaoxia Dai iD, Yuxiang Sun, Jun Yuan, Sanat Afzalpurkar, Connor Duong, Albert Yu, Feng Tang iD, Xiaomei He, Xiaochuan Liu, Xingyuan Chen und 2 weitere

Nucleic Acids Research · 24.02.2026 · 54 (5)

DOI: 10.1093/nar/gkag194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 03.03.2026. Verfasst von Xiaochen Liang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Environmental Toxicology Graduate Program, University of California, Riverside, CA 92521-0403, United States. Hauptthemen laut MEDLINE: RNA-Binding Protein FUS, Adenosine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleotide repeat expansions contribute to a number of neurological disorders. Mutations and augmented expression in fused in sarcoma (FUS) can result in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Here we reveal that FUS is an N1- and N6-methyladenosine (m1A- and m6A)-binding protein, where the protein interacts with the methylated adenosines in CAG repeat expansion RNA, thereby leading to the protein’s cytoplasmic redistribution in SH-SY5Y cells. We also found that ectopically expressed FUS co-localizes with CAG repeat RNA in the cytosol. This co-localization is diminished upon genetic depletion of m6A and m1A writer proteins (i.e. METTL3 and TRMT61A), pharmacological inhibition of METTL3, and ectopic overexpression of m1A and m6A eraser proteins (i.e. ALKBH3 and FTO). Moreover, binding to methylated CAG repeat RNA renders the ectopically expressed FUS protein less dynamic in cells. Together, our study underscores a critical role for m1A and m6A in enhancing FUS–RNA interaction, which results in aberrant subcellular distribution and attenuated mobility of the protein in cells. These findings unveil a novel mechanism underlying neurodegenerative disorders emanating from elevated expression of FUS and suggest targeting FUS-methylated adenosine interactions as a potential therapeutic strategy for FUS proteinopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding Protein FUSAdenosineHumansRNA MethylationMethyltransferasesCell Line, TumorProtein Binding

Substanzen

RNA-Binding Protein FUSAdenosineN-methyladenosineMethyltransferasesFUS protein, humanMETTL3 protein, human

Autor:innen und Institutionen

  • Environmental Toxicology Graduate Program, University of California, Riverside, CA 92521-0403, United States.
  • Department of Chemistry, University of California, Riverside, CA 92521-0403, United States.

ORCID-Profile: Xiaoxia Dai, Feng Tang

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Liang, X., Zhao, T., Dai, X., Sun, Y., Yuan, J., Afzalpurkar, S., Duong, C., Yu, A., Tang, F., He, X., Liu, X., Chen, X., Cao, Z., & Wang, Y. (2026). FUS is an N 1- and N 6-methyladenosine-binding protein. Nucleic Acids Research, 54(5). https://doi.org/10.1093/nar/gkag194

Vancouver

Liang X, Zhao T, Dai X, Sun Y, Yuan J, Afzalpurkar S, et al. FUS is an N 1- and N 6-methyladenosine-binding protein. Nucleic Acids Research. 2026;54(5). doi:10.1093/nar/gkag194

BibTeX
@article{Liang2026,
  author = {Liang, Xiaochen and Zhao, Ting and Dai, Xiaoxia and Sun, Yuxiang and Yuan, Jun and Afzalpurkar, Sanat and Duong, Connor and Yu, Albert and Tang, Feng and He, Xiaomei and Liu, Xiaochuan and Chen, Xingyuan and Cao, Zhongwen and Wang, Yinsheng},
  title = {FUS is an N 1- and N 6-methyladenosine-binding protein},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {5},
  doi = {10.1093/nar/gkag194}
}
Kostenlos starten →